MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

@article{Londoo2007MELDSA,
  title={MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.},
  author={Mar{\'i}a Carlota Londo{\~n}o and Andres Cardenas and M{\'o}nica Ladr{\'o}n de Guevara and Llorenç Quint{\'o} and Dara de Las Heras and Miguel Navasa and Antoni Rimola and Juan-Carlos Garc{\'i}a-Valdecasas and Vicente Arroyo and Pere Gin{\`e}s},
  journal={Gut},
  year={2007},
  volume={56 9},
  pages={1283-90}
}
BACKGROUND/AIMS Serum sodium predicts prognosis in cirrhosis and may improve the prognostic accuracy of the model for end-stage liver disease (MELD) score, but the available information is limited. The aim of the present study was to assess the prognostic value of serum sodium in the prediction of survival at 3 and 12 months after listing in patients with cirrhosis awaiting liver transplantation, and to compare its predictive value with that of the MELD score. PATIENTS AND METHODS 308… CONTINUE READING
71 Citations
42 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Effects of a selective vasopressin V 2 receptor antagonist , Satavaptan ( SR 121463 B ) , on recurrence of ascites after large volume paracentesis [ abstract ]

  • F Wong, P Ginès, H Watson
  • Hepatology
  • 2006

Effects of satavaptan ( SR 121463 B ) , a selective vasopressin V 2 receptor antagonist , on serum sodium concentration and ascities in patients with cirrhosis and hyponatremia

  • P Ginès, F Wong, S Milutinovic
  • J Hepatol
  • 2006

Hyponatremia predispones to hepatic encephalopathy in patients with cirrosis . Results of prospective study with time - dependent analysis [ abstract ]

  • ME Baccaro, M Guevara, A Torre
  • Hepatology
  • 2006

Similar Papers

Loading similar papers…